Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The SURPASS-EARLY study was published on May 25,2026 in the Annals of Internal Medicine
Long-term management strategies: Slow dose escalation (extend any phase if needed) Take medication with food Avoid high-fat meals during dose increases Stay hydrated Over-the-counter anti-nausea aids (ginger, vitamin B6) For comprehensive side effect management information, see our complete side effects guide
GHK-Cu acts primarily through modulation of gene expression and oxidative stress
Even more impressively, the SELECT trial tracked over 17,000 participants for an average of nearly three and a half years and not only confirmed the medication's safety but also showed it reduced major cardiovascular events by 20% compared to placebo
US$ 27.21
US$ 26.98
US$ 29.79
US$ 26.75
US$ 28.91
US$ 27.75
US$ 20.96
US$ 25.16
